Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19()

The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation an...

Descripción completa

Detalles Bibliográficos
Autores principales: Brain, Danielle, Plant-Hately, Alex, Heaton, Bethany, Arshad, Usman, David, Christopher, Hedrich, Christian, Owen, Andrew, Liptrott, Neill J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233062/
https://www.ncbi.nlm.nih.gov/pubmed/34182016
http://dx.doi.org/10.1016/j.addr.2021.113848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233062/
https://www.ncbi.nlm.nih.gov/pubmed/34182016
http://dx.doi.org/10.1016/j.addr.2021.113848

Ejemplares similares